SB 752

Amends GS 115C-375.2 by amending the provision governing the policies adopted by local boards of education regulating when a student with asthma or subject to anaphylactic reactions can possess and self-administer asthma medication to define asthma medication to include epinephrine products, no longer limiting it to epinephrine auto injectors. Makes conforming changes to refer to the use of "epinephrine product"" instead of ""epinephrine auto injectors"" in GS 115C-375.2A (concerning school supply of epinephrine delivery systems), GS 115C-218.75 (concerning health and safety standards for charter schools), and GS 115C-238.66 (concerning the supply of epinephrine delivery systems in regional schools). Also amends GS 115C-375.2A to provide that ""epinephrine product"" includes nasal sprays and injectors with a spring-activated concealed needle. Applies beginning with the 2025-26 school year."